518
Views
7
CrossRef citations to date
0
Altmetric
Review Articles: Obstetrics

Measuring the severity of nausea and vomiting of pregnancy; a 20-year perspective on the use of the pregnancy-unique quantification of emesis (PUQE)

&

References

  • Balık G, Tekin YB, Kağıtcı M. 2015. Is there relationship between social support, psychological distress, mood disorders and emesis gravidarum? Journal of Obstetrics and Gynaecology 35:737–740.
  • Birkeland E, Stokke G, Tangvik RJ, Torkildsen EA, Boateng J, Wollen AL, et al. 2015. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study. PLOS One 10:e0119962.
  • Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V, et al. 2018. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 31:2492–2505.
  • Caritis S, Zhao Y, Chen H-J, Venkataramanan R. 2016. Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology 215:93.e1-4–93.e4.
  • Cengiz H, Dagdeviren H, Caypinar SS, Kanawati A, Yildiz S, Ekin M, et al. 2015. Plasma serotonin levels are elevated in pregnant women with hyperemesis gravidarum. Archives of Gynecology and Obstetrics 291:1271–1276.
  • Chetry M, Thakur A, Uprety DK, et al. 2016. Hyperemesis gravidarum in a tertiary care centre in easternnepal; a prospective observational study. Journal of Ayub Medical College of Abbottabad. 28:18–21.
  • Ebrahimi N, Maltepe C, Bournissen FG, Koren G. 2009. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. Journal of Obstetrics and Gynaecology Canada 31:803–807.
  • Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes Å, et al. 2019. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nature Reviews: Disease Primers 5:62
  • Gill SK, Maltepe C, Koren G. 2009a. The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing the severity of nausea and vomiting of pregnancy. Journal of Obstetrics and Gynaecology 29:13–16.
  • Gill SK, Maltepe C, Koren G. 2009b. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Canadian Journal of Gastroenterology 23:270–272. Apr
  • Grooten IJ, Mol BW, van der Post JAM, Ris-Stalpers C, Kok M, Bais JMJ, et al. 2016. Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding). BMC Pregnancy Childbirth 16:22.
  • Jafari-Dehkordi E, Hashem-Dabaghian F, Aliasl F, Aliasl J, Taghavi-Shirazi M, Sadeghpour O, et al. 2017. Comparison of quince with vitamin B6 for treatment of nausea and vomiting in pregnancy: a randomised clinical trial. Journal of Obstetrics and Gynaecology 37:1048–1052.
  • Joulaeerad N, Ozgoli G, Hajimehdipoor H, et al. 2018. Effect of aromatherapy with peppermint oil on the severity of nausea and vomiting in pregnancy: a single-blind, randomized, placebo-controlled trial. Journal of Reproduction and Infertility 19:32–38.
  • Kan E, Emektar E, Corbacioglu K, et al. 2019. Evaluation of relationship between inflammatory markers and hyperemesis gravidarum in patients admitted to emergency department. American Journal of Emergency Medicine. May 4:30301–30308. [Epub ahead of print]
  • Klauser C, Fox N, Istwan N, Rhea D, Rebarber A, Desch C, et al. 2011. Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications. American Journal of Perinatology 28:715–721.
  • Koot MH, Grooten IJ, van der Post JAM, Bais JMJ, Ris-Stalpers C, Leeflang MMG, et al. 2020. Determinants of disease course and severity in hyperemesis gravidarum. European Journal of Obstetrics and Gynecology and Reproductive Biology 245:162–167. Feb
  • Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A, et al. 2002. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology 186:S228–S31. May
  • Koren G, Clark S, Hankins GDV, Caritis SN, Umans JG, Miodovnik M, et al. 2016. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. BMC Pregnancy and Childbirth 16:371
  • Koren G, Clark S, Hankins GDV, Caritis SN, Umans JG, Miodovnik M, et al. 2015. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. BMC Pregnancy Childbirth 15:59
  • Koren G, MacLeod SM. 1986. Monitoring and avoiding drug and chemical teratogenicity. Canadian Medical Association Journal 15:1079–1081.
  • Koren G, Magee L, Attard C, Kohli M, Atanackovic G, Bishai R, et al. 2001. A novel method for the evaluation of the severity of nausea and vomiting of pregnancy. European Journal Obstetrics and Gynaecology and Reproductive Biology 94:31–36.
  • Koren G, Nulman I, Aleksa K, Gareri J, Einarson A, Ito S, et al. 2012. Essay for the 2011 CIHR/CMAJ award: Motherisk – caring for mothers, protecting the unborn. Canadian Medical Association Journal 184:E155–7.
  • Koren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A, et al. 2005. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. Journal of Obstetrics and Gynaecology 25:241–244.
  • Lehmann AS, Renbarger JL, McCormick CL, Topletz AR, Rouse C, Haas DM, et al. 2013. Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study. BMC Pregnancy and Childbirth 13:132.
  • London V, Grube S, Sherer DM, Abulafia O. 2017. Hyperemesis gravidarum: a review of recent literature. Pharmacology 100:161–171.
  • Magee LA, Mazzotta P, Koren G. 2002. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). American Journal of Obstetrics and Gynecology 186:S256–S61.
  • Maina A, Arrotta M, Cicogna L, Donvito V, Mischinelli M, Todros T, et al. 2014. Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI. BJOG 121:1556–1562. Nov
  • Malek NZH, Kalok A, Hanafiah ZA, Azhar Shah S, Ismail NAM. 2017. Association of transient hyperthyroidism and severity of hyperemesis gravidarum. Hormonal and Molecular Biological Clinical Investigation 30:20160050.
  • Mazzotta P, Gupta A, Maltepe C, Koren G, Magee L. 1998. Pharmacologic treatment of nausea and vomiting during pregnancy. Canadian Family Physician Medecin de Famille Canadien 44:1455–1457.
  • McParlin C, Carrick-Sen D, Steen IN, Robson SC. 2016. Hyperemesis in pregnancy study: a pilot randomised controlled trial of midwife-led outpatient care. European Journal of Obstetrics, Gynecology, and Reproductive Biology 200:6–10.
  • Mendoza E, Amsler F. 2017. A randomized crossover trial on the effect of compression stockings on nausea and vomiting in early pregnancy. International Journal of Women's Health 9:89–99.
  • Mitchell-Jones N, Farren JA, Tobias A, Bourne T, Bottomley C. 2017. Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm. BMJ Open 7:e017566.
  • Onder AB, Guven S, Demir S, Mentese A, Guvendag Guven ES. 2019. Biotin deficiency in hyperemesis gravidarum. Journal of Obstetrics and Gynaecology 39:1160–1164.
  • Piwko C, Ungar WJ, Einarson TR, Wolpin J, Koren G. 2007. The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program. Current Medical Research and Opinion 23:833–840.
  • Pope E, Maltepe C, Koren G. 2015. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: a matched, controlled cohort study. The Journal of Clinical Pharmacology 55:809–814.
  • Sahin E, Madendag Y, Eraslan Sahin M, Tayyar AT, Col Madendag I, Gozukucuk M, et al. 2018. Maternal type 1collagen N-terminal telopeptide levels in severe hyperemesis gravidarum. BMC Pregnancy and Childbirth 18:502.
  • Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, et al. 2018. Area postrema syndrome: frequency, criteria, and severity in AQP4-IgG-positive NMOSD. Neurology 91:e1642–e1651.
  • Trovik J, Vikanes AV. 2019. Antiemetics in hyperemesis gravidarum: unawareness or negligence? BJOG 126:1212
  • Tunc SY, Agacayak E, Budak S, Tunc N, Icen MS, Findik FM, et al. 2016. Serum levels of neopterin, inflammatory markers and oxidative stress indicators in hyperemesis gravidarum. Journal of Obstetrics and Gynaecology Research 42:618–624.
  • Yavari Kia P, Safajou F, Shahnazi M, et al. 2014. The effect of lemon inhalation aromatherapy on nausea and vomiting of pregnancy: a double-blinded, randomized, controlled clinical trial. Iran Red Crescent Medical Journal 16:e14360.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.